Red, itchy, and scaly skin from atopic dermatitis and eczema can be uncomfortable, confusing, and all too familiar.

AD is a growing market with an impressive pipeline of new products from current and future players in the field.

Tralokinumab use in patients with head and neck atopic dermatitis was associated with sustained improvements with up to 4 years of treatment.

Significant research has documented the impact of atopic dermatitis on mental health. Not only does stress trigger eczema ...

Evommune launches mid-stage trials for immune-modulating drugs targeting skin conditions, backed by $115M funding and led by ...

Recent clinical studies have started showing the benefits of using vitamin B12 cream to help manage dermatitis. Vitamin B12 ...

A new study published in the Journal of European Academy of Dermatology and Venerology showed that compared to patients on ...

Raj Chovatiya, MD, PhD, MSCI, highlights the long-term effectiveness of lebrikizumab across diverse patients, including those with prior biologic use, positioning it as a potential first-line ...

Intellectual disabilities, food allergies, and asthma were all more common in children who took multiple courses of ...

Moreover, an independently-funded feasibility study in atopic dermatitis showed a reduction in skin lesion severity and extension by over 40% and a near 50% reduction in the overall severity of ...

There are four main subtypes of HD: contact dermatitis (irritant or al lergic dermatitis), atopic hand dermatitis, pomphylox (dyshidrotic ec zema), and hyperkeratotic dermatitis (Warshaw et al., ...